Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma

British Journal of Surgery

Volumn 88, Issue 12, 2001, Pages 1596-1601

  Yukawa, N ^a,c   Yoshikawa, T ^a   Akaike, M ^b   Sugimasa, Y ^b   Takemiya, S ^c   Yanoma, S ^a   Noguchi, Y ^b   Takanashi, Y ^c  

^a KANAGAWA CANCER CENTER   (Japan)

^b Yokohama Kowan Hospital   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACCURACY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROSA;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 0035213284     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.01930.x     Document Type: Article

References (31)

1. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo
2. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression
3. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia
4. Tissue inhibitor of metalloproteinase (TIMP, aka EPA): Structure, control of expression and biological functions
5. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
6. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
7. Clinical significance of tissue inhibitor of metallo-proteinase expression in gastric carcinoma
8. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases
9. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer
10. Tissue inhibitor of metalloproteinase-1 in the plasma of patients with gastric carcinoma. A possible marker for serosal invasion and metastasis
11. Serum metalloproteinases and their inhibitors: Markers for malignant potential
12. Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
13. Limited value of preoperative serum analysis of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
14. The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: Possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis
15. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma
16. Diagnosis of gastric cancer
17. Molecular biological observations in gastric cancer
18. Marked elevation of plasma carcinoembrionic antigen and stomach cancer
19. The clinical usefulness of preoperative CEA determination in gastric cancer
20. Evaluation of seven tumor markers (CA50, CA19-9, TruQuant, CA72-4, CA195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma
21. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
22. Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain
23. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells
24. A matrix metalloproteinase expressed on the surface of invasive tumour cells
25. Role of tissue inhibitors of metalloproteinase (TIMPs) in colorectal carcinoma
26. Port site metastasis after laparoscopic colorectal surgery for cure of malignancy
27. Tumor size of colorectal cancer: Indication for laparoscopic surgery
28. Laparoscopic colo-rectal surgery: Analysis of 113 cases
29. Preoperative chemoradiation and coloanal J pouch reconstruction for low rectal cancer
30. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography